{"gene":"TLR9","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":2000,"finding":"TLR9 is the essential pattern recognition receptor for bacterial CpG DNA; TLR9-deficient mice fail to respond to CpG DNA stimulation, including splenocyte proliferation, inflammatory cytokine production, dendritic cell maturation, and in vivo Th1 responses, establishing TLR9 as the receptor that distinguishes bacterial from self-DNA.","method":"TLR9 knockout mice, in vitro stimulation assays, in vivo cytokine measurement","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 — foundational KO study with multiple orthogonal readouts, highly replicated across the field","pmids":["11130078"],"is_preprint":false},{"year":2004,"finding":"TLR9 resides in the endoplasmic reticulum at steady state and translocates to CpG DNA-containing lysosomal compartments upon ligand uptake, where it co-accumulates with MyD88 and initiates signaling; this established a previously unknown mechanism of immune receptor activation requiring ER-to-lysosome translocation.","method":"Fluorescence microscopy, subcellular fractionation, co-localization studies in dendritic cells and macrophages, ligand-binding studies","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple imaging and biochemical approaches in primary cells, independently confirmed","pmids":["14716310"],"is_preprint":false},{"year":2004,"finding":"TLR9 binds directly and sequence-specifically to single-stranded unmethylated CpG-DNA at acidic pH (6.5–5.0) matching endosomal/lysosomal conditions; a CpG-DNA binding domain homologous to methyl-CpG-binding proteins was identified, and amino acid substitutions in this region abrogated both CpG-DNA binding and NF-κB activation.","method":"Direct binding assays, site-directed mutagenesis, NF-κB reporter assays","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — direct binding assay combined with mutagenesis and functional readout","pmids":["15307186"],"is_preprint":false},{"year":2004,"finding":"Human TLR9 gene transcription is regulated by four cis-acting elements (CRE, 5'-PU box, 3'-PU box, C/EBP site) interacting with CREB1, Ets2, Elf1, Elk1, and C/EBPα transcription factors; CpG DNA-mediated suppression of TLR9 transcription involves c-Jun and NF-κB p65.","method":"Reporter gene analysis, EMSA, transcription factor identification in human myeloma cells","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical methods (reporter + EMSA) in single cell type","pmids":["15294971"],"is_preprint":false},{"year":2005,"finding":"DNA-containing immune complexes in lupus serum activate plasmacytoid DCs through cooperative interaction between TLR9 and FcγRIIa (CD32); CD32 delivers SLE immune complexes to intracellular lysosomes containing TLR9, inducing a signaling cascade leading to PDC activation.","method":"Subcellular co-localization microscopy, functional assays with CD32+ vs CD32- PDCs, cytokine measurement","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — co-localization, receptor-blocking experiments, and functional cytokine readout with defined receptor requirements","pmids":["15668740"],"is_preprint":false},{"year":2005,"finding":"DNA-PKcs, not TLR9, is the primary mediator of CpG-DNA-induced Akt phosphorylation and activation; in vitro reconstitution showed DNA-PK directly phosphorylates Akt, and DNA-PKcs associates with Akt upon CpG-DNA stimulation to trigger transient nuclear translocation of Akt in macrophages.","method":"DNA-PKcs and TLR9 KO macrophages, in vitro kinase assay with purified proteins, co-immunoprecipitation, nuclear fractionation","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with purified proteins plus genetic KO controls and Co-IP","pmids":["15678105"],"is_preprint":false},{"year":2006,"finding":"Apical vs. basolateral TLR9 signaling in polarized intestinal epithelial cells produces distinct transcriptional responses: basolateral TLR9 activates NF-κB via IκBα degradation, whereas apical TLR9 stimulation causes ubiquitinated IκB accumulation without NF-κB activation and confers tolerance to subsequent TLR challenges, maintaining colonic homeostasis.","method":"Polarized epithelial cell culture, NF-κB reporter assays, cDNA microarray, TLR9-deficient mouse model of colitis","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 — defined compartment-specific signaling with multiple readouts in both cell culture and in vivo KO model","pmids":["17128265"],"is_preprint":false},{"year":2006,"finding":"The endosomal location of TLR9 activation—not oligonucleotide valency—determines the nature of the plasmacytoid DC response: TfR+ early endosomes drive IFN-α production while LAMP1+ lysosomes drive PDC maturation; altering CpG oligonucleotide localization by encapsulation redistributes the response.","method":"Endosomal fractionation, confocal microscopy, liposome encapsulation to redirect compartmental localization, cytokine assays in primary human PDCs","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple complementary experimental approaches establishing compartment-response relationship","pmids":["16864658"],"is_preprint":false},{"year":2008,"finding":"Protein kinase D1 (PKD1) is activated downstream of TLR9 via a pathway requiring endosomal pH, MyD88, and IRAK1; upon CpG-B DNA stimulation PKD1 interacts with the TLR9/MyD88/IRAK1/TRAF6 complex and is required for NF-κB and MAPK activation and subsequent cytokine expression.","method":"PKD1 knockdown (siRNA), Co-immunoprecipitation, kinase activity assays, NF-κB reporter assays in macrophages","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP and KD in single lab with multiple pathway readouts","pmids":["18641342"],"is_preprint":false},{"year":2010,"finding":"TLR9 is required for innate immune response to CpG DNA in chicken macrophages via a distinct receptor (chTLR21), demonstrating convergent evolution; in mammalian cells, TLR9 localizes to the same intracellular compartments as chTLR21, and endosomal maturation is required for functional signaling.","method":"Receptor cloning, HEK293 transfection, gene silencing in chicken macrophages, confocal microscopy, pharmacological inhibition","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — functional characterization with multiple methods; primarily characterizes chTLR21 but validates TLR9 endosomal localization and function","pmids":["20498358"],"is_preprint":false},{"year":2012,"finding":"Cell-type-specific differences exist in TLR9 trafficking and proteolytic processing: in macrophages, TLR9 cleavage requires both cathepsins L and S, whereas in B cells only cathepsin L is required; processing rate is faster in B cells, which show predominantly endolysosomal TLR9 localization at rest; UNC93B1 expression level is tightly correlated with TLR9-GFP cleavage and is required for processing in all cell types.","method":"Transgenic TLR9-GFP mice, live-cell imaging, pharmacological cathepsin inhibition, UNC93B1 3d mutant mice","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — in vivo transgenic model with multiple cell types and pharmacological/genetic dissection of cathepsin requirements","pmids":["23241879"],"is_preprint":false},{"year":2013,"finding":"TLR9 stimulation in cardiomyocytes and neurons activates a non-canonical pathway that reduces energy substrates, raises the AMP/ATP ratio, and activates AMPK to increase stress tolerance against hypoxia, without inducing canonical inflammatory responses; UNC93B1 expression acts as a pivotal switch regulating subcellular localization of TLR9 and determines which signaling pathway is activated in a cell-type-specific manner.","method":"Primary cardiomyocyte and neuronal culture, TLR9 stimulation, AMPK activity assays, metabolic measurements, UNC93B1 manipulation, hypoxia survival assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical readouts in primary cells with defined molecular switch (UNC93B1)","pmids":["23479602"],"is_preprint":false},{"year":2014,"finding":"RNA:DNA hybrids are recognized by TLR9 as a novel molecular pattern; MyD88-dependent signaling is essential for cytokine responses induced by RNA:DNA hybrids containing viral sequences in dendritic cells.","method":"MyD88-deficient cells, TLR9-specific knockdown/KO, cytokine production assays, synthetic RNA:DNA hybrids","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO/KD with defined ligand in primary DCs","pmids":["24514026"],"is_preprint":false},{"year":2015,"finding":"DNase II enzymatic activity is required for TLR9 activation by CpG-A (but not CpG-B) and by bacterial genomic DNA; DNase II cleaves CpG-A from 20-mer to 11–12-mer fragments, and these 3'-11-mer fragments activate DNase II-deficient DCs, demonstrating that TLR9 responds to DNA fragments generated by lysosomal DNase II rather than intact DNA.","method":"DNase II-deficient DCs, enzymatically inactive DNase II mutants, co-localization microscopy, stimulation with defined DNA fragments","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — enzymatic mutants plus KO cells plus defined fragment rescue, multiple orthogonal approaches","pmids":["25600358"],"is_preprint":false},{"year":2016,"finding":"Dectin-1 controls TLR9 trafficking to phagosomes containing β-1,3 glucan via spleen tyrosine kinase (Syk) activation; phagosomal acidification and Dectin-1-mediated Syk signaling are both required for TLR9 accumulation at fungal phagosomes, and Dectin-1 regulates TLR9-dependent gene expression.","method":"Confocal microscopy, pharmacological inhibition of Syk and endosomal acidification, Dectin-1-deficient cells, gene expression assays","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — defined receptor requirements for trafficking with multiple inhibitor and genetic approaches","pmids":["26829985"],"is_preprint":false},{"year":2017,"finding":"BAD-LAMP (LAMP5) controls TLR9 trafficking to LAMP1+ late endosomes in plasmacytoid DCs, promoting NF-κB activation and TNF production; a separate VAMP3+/LAMP2+/LAMP1- compartment supports IFN-α production, and BAD-LAMP silencing enhances TLR9 retention in this IFN-α-inducing compartment, while BAD-LAMP overexpression suppresses IFN-α.","method":"siRNA silencing, confocal microscopy, compartment characterization, cytokine measurement in primary human pDCs","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — compartment-specific trafficking with functional consequences defined by gain- and loss-of-function in primary cells","pmids":["29030552"],"is_preprint":false},{"year":2017,"finding":"Glucocorticoid receptor (GR) suppresses TLR9-induced inflammation via a transcription-independent mechanism by physically interacting with IRAK1 and blocking β-TrCP-mediated K48-linked ubiquitination of IRAK1 at Lys134; this prevents membrane-to-cytoplasm trafficking of TRAF6 and TAK1 and downstream NF-κB/MAPK activation, an effect specific to TLR9 and not TLR4.","method":"Co-immunoprecipitation, site-directed mutagenesis (K134 IRAK1), GR KO macrophages, ubiquitination assays, cytokine measurement","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis plus Co-IP plus KO macrophages establishing specific PTM requirement","pmids":["29038250"],"is_preprint":false},{"year":2018,"finding":"Dengue virus (an RNA virus) activates TLR9 in human dendritic cells by inducing release of mitochondrial DNA (mtDNA) into the cytosol; this involves reactive oxygen species generation, inflammasome activation, disruption of TFAM-mtDNA association, and activation of mitochondrial permeability transition pores; both TLR9 and cGAS comparably contribute to DENV-induced immune activation.","method":"TLR9 and cGAS siRNA knockdown, TLR9 KO mouse bone marrow-derived DCs, mtDNA release quantification, ROS measurement, cytokine assays","journal":"EMBO reports","confidence":"Medium","confidence_rationale":"Tier 2 — parallel KD/KO with multiple mechanistic readouts, single study","pmids":["29880709"],"is_preprint":false},{"year":2019,"finding":"CD82 (a tetraspanin) is a key regulator of TLR9 trafficking and signaling; TLR9 and CD82 associate in the ER and post-ER compartments of macrophages, and CD82 is essential for TLR9-dependent myddosome formation and NF-κB nuclear translocation in response to CpG stimulation.","method":"Co-immunoprecipitation, confocal microscopy, CD82-deficient macrophages, NF-κB nuclear translocation assays, myddosome complex analysis","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP plus functional KO with pathway readout in single study","pmids":["31408613"],"is_preprint":false},{"year":2022,"finding":"Genetic dissection using TLR9 point mutants in lupus-prone mice revealed that TLR9 has distinct signaling modes: (1) a ligand- and MyD88-independent 'scaffold' protective function; (2) a ligand-dependent but MyD88-independent regulatory signaling function (B cell-intrinsic, restraining age-associated B cells and plasmablasts); and (3) a MyD88-dependent proinflammatory signaling function.","method":"TLR9 point mutant knockin mice (TLR9K51E lacking ligand binding; TLR9P915H lacking MyD88 binding), bone marrow chimeras, flow cytometry, disease phenotyping","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple precise knockin alleles plus chimera experiments dissecting distinct functional domains","pmids":["36151396"],"is_preprint":false},{"year":2024,"finding":"TLR9 undergoes a cycle of S-palmitoylation and depalmitoylation that controls its endosomal signaling: DHHC3 palmitoylates TLR9 at C258 and C265 in the Golgi and regulates its trafficking to endosomes; PPT1 removes S-palmitoylation from TLR9 in lysosomes and facilitates TLR9 release from UNC93B1, promoting IFN-α secretion by pDCs and TNF by macrophages.","method":"Mass spectrometry (palmitoylation site identification), site-directed mutagenesis (C258/C265), PPT1 KO/inhibition, DHHC3 manipulation, biochemical palmitoylation assays, cytokine measurements in vitro and in vivo","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — MS-identified PTM sites confirmed by mutagenesis, genetic KO and chemical inhibition with multiple orthogonal readouts","pmids":["38169466"],"is_preprint":false},{"year":2024,"finding":"TLR9 signaling in hippocampal CA1 neurons is required for memory formation; learning induces dsDNA breaks and nuclear envelope ruptures in discrete neuronal clusters, triggering TLR9 activation; neuron-specific Tlr9 knockdown impairs contextual fear memory and TLR9 has an essential role in centrosome function including DNA damage repair, ciliogenesis, and perineuronal net formation.","method":"Neuron-specific Tlr9 knockdown, contextual fear conditioning, gene expression profiling of CA1 neuron clusters, centrosome functional assays, imaging of dsDNA breaks","journal":"Nature","confidence":"Medium","confidence_rationale":"Tier 2 — neuron-specific KD with behavioral and molecular phenotypes, single study","pmids":["38538785"],"is_preprint":false},{"year":2024,"finding":"EBV suppresses TLR9 expression by downregulating N6-methyladenosine (m6A) modification of TLR9 mRNA; EBNA1 promotes K48-linked ubiquitin-proteasome degradation of METTL3 (m6A writer), reducing TLR9 mRNA stability; YTHDF1 acts as an m6A reader that enhances TLR9 translation, and loss of METTL3/YTHDF1 reduces TLR9 protein expression and impairs TLR9-dependent B cell responses.","method":"METTL3/YTHDF1 knockdown, m6A site mapping, ubiquitination assays, protein stability assays, B cell functional assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple molecular components identified with loss-of-function, single study","pmids":["38537697"],"is_preprint":false}],"current_model":"TLR9 is an endosomal pattern recognition receptor that resides in the ER at steady state and, upon CpG DNA uptake, translocates to lysosomes where it directly binds unmethylated CpG DNA at acidic pH (facilitated by DNase II-generated fragments and S-palmitoylation cycling by DHHC3/PPT1 that controls its association with the trafficking chaperone UNC93B1); ligand engagement initiates MyD88-dependent signaling through IRAK1 (regulated by ubiquitination and PKD1), with signaling outcome determined by subcellular compartment—early endosomes driving IFN-α production and late lysosomes driving NF-κB/TNF responses—while accessory proteins including CD32, BAD-LAMP, CD82, and Dectin-1 regulate TLR9 trafficking to specific compartments; beyond immune cells, TLR9 activates AMPK-dependent stress protection in cardiomyocytes/neurons and, via a MyD88-independent scaffold function in B cells, suppresses lupus pathogenesis."},"narrative":{"teleology":[{"year":2000,"claim":"Establishing TLR9 as the non-redundant receptor for bacterial CpG DNA resolved the long-standing question of how the innate immune system discriminates microbial from self-DNA.","evidence":"TLR9 knockout mice showing complete loss of CpG DNA responses across multiple readouts (proliferation, cytokines, DC maturation, Th1 polarization)","pmids":["11130078"],"confidence":"High","gaps":["Ligand binding mechanism not yet defined","Subcellular site of receptor activation unknown","Signaling intermediates downstream of TLR9 not mapped"]},{"year":2004,"claim":"The discovery that TLR9 resides in the ER and must translocate to CpG-containing lysosomes to signal overturned the assumption that TLR activation occurs at the plasma membrane, establishing a new paradigm of intracellular innate receptor activation.","evidence":"Fluorescence microscopy and subcellular fractionation in primary DCs and macrophages showing ER residence and ligand-induced redistribution to LAMP1+ compartments with MyD88 co-recruitment","pmids":["14716310"],"confidence":"High","gaps":["Molecular chaperone(s) required for ER-to-endosome trafficking not identified","Mechanism of pH-dependent ligand recognition not resolved"]},{"year":2004,"claim":"Demonstrating direct, pH-dependent, sequence-specific CpG DNA binding by TLR9 and identifying a CpG-binding domain resolved how ligand specificity is achieved in the acidic endolysosomal environment.","evidence":"Direct binding assays at acidic pH combined with site-directed mutagenesis abolishing both binding and NF-κB activation","pmids":["15307186"],"confidence":"High","gaps":["Crystal structure of TLR9–CpG complex not available","Structural basis for methylation discrimination unresolved"]},{"year":2005,"claim":"Identifying that FcγRIIa (CD32) delivers DNA-containing immune complexes to TLR9-positive lysosomes in plasmacytoid DCs provided a mechanistic link between autoantibody-mediated uptake and TLR9 activation in systemic lupus erythematosus.","evidence":"Co-localization of CD32-internalized SLE immune complexes with TLR9 in lysosomes; receptor-blocking experiments abolishing PDC activation","pmids":["15668740"],"confidence":"High","gaps":["Relative contribution of CD32-dependent vs -independent uptake in different DC subsets unclear","Whether other Fc receptors cooperate not tested"]},{"year":2006,"claim":"Demonstrating that the endosomal compartment of TLR9 activation—early endosome vs. late lysosome—determines whether IFN-α or NF-κB/maturation responses are elicited established compartmentalized signaling as a core principle of TLR9 biology.","evidence":"Endosomal fractionation and liposome-mediated redirection of CpG localization in primary human pDCs with cytokine readouts","pmids":["16864658"],"confidence":"High","gaps":["Specific adaptor molecules distinguishing compartment-specific signaling not fully identified","How retention time in each compartment is regulated unknown"]},{"year":2006,"claim":"Showing that apical vs. basolateral TLR9 stimulation in polarized epithelial cells produces opposing NF-κB outcomes extended TLR9 compartment-dependent signaling to non-immune cells and implicated it in intestinal homeostasis.","evidence":"Polarized epithelial cell culture with NF-κB reporters and microarray, plus TLR9-deficient colitis model","pmids":["17128265"],"confidence":"High","gaps":["Molecular mechanism of apical I-κBα ubiquitination without degradation not defined","In vivo epithelial-specific TLR9 contribution not separated from immune cell contribution"]},{"year":2012,"claim":"Identifying cell-type-specific cathepsin requirements for TLR9 proteolytic processing and demonstrating UNC93B1 as a universal regulator of this processing clarified how TLR9 activation is differentially tuned across immune lineages.","evidence":"TLR9-GFP transgenic mice analyzed in macrophages and B cells with cathepsin inhibitors and UNC93B1 3d mutant mice","pmids":["23241879"],"confidence":"High","gaps":["Precise cleavage sites in TLR9 not mapped","Functional consequence of differential processing kinetics on signaling output not quantified"]},{"year":2013,"claim":"Discovery of a non-canonical TLR9–AMPK stress-protection pathway in cardiomyocytes and neurons, gated by UNC93B1 expression level, revealed that TLR9 functions beyond immunity as a metabolic sensor in non-immune cells.","evidence":"Primary cardiomyocyte and neuronal cultures showing CpG-induced AMP/ATP ratio increase, AMPK activation, and hypoxia protection without inflammatory cytokine induction; UNC93B1 manipulation switching pathway usage","pmids":["23479602"],"confidence":"Medium","gaps":["Endogenous ligand triggering this pathway in vivo not identified","Whether AMPK activation is direct or through intermediate kinases unknown","Not independently replicated in a second laboratory"]},{"year":2015,"claim":"Establishing that DNase II generates the short CpG DNA fragments actually recognized by TLR9 in lysosomes redefined the ligand from intact CpG DNA to processed 11–12-mer fragments for at least some agonist classes.","evidence":"DNase II-deficient and enzymatically dead DCs showing loss of CpG-A responses; rescue by synthetic 3'-11-mer fragments","pmids":["25600358"],"confidence":"High","gaps":["Whether all TLR9 ligand classes require DNase II processing not resolved","Structural basis for fragment-length preference unknown"]},{"year":2017,"claim":"Identification of BAD-LAMP as a trafficking regulator that directs TLR9 toward LAMP1+ late endosomes (promoting NF-κB/TNF) and away from VAMP3+/LAMP2+ IFN-α-inducing compartments provided a molecular handle on compartment-dependent signaling in pDCs.","evidence":"BAD-LAMP silencing and overexpression in primary human pDCs with compartment characterization and cytokine quantification","pmids":["29030552"],"confidence":"High","gaps":["BAD-LAMP interaction surface on TLR9 not mapped","Whether BAD-LAMP regulates other endosomal TLRs not tested"]},{"year":2017,"claim":"Demonstration that glucocorticoid receptor suppresses TLR9-specific signaling by physically blocking IRAK1 K48-ubiquitination at K134 revealed a transcription-independent anti-inflammatory checkpoint unique to the TLR9 pathway.","evidence":"GR KO macrophages, IRAK1 K134 mutagenesis, ubiquitination assays, and Co-IP showing GR–IRAK1 interaction","pmids":["29038250"],"confidence":"High","gaps":["Whether GR-IRAK1 interaction is direct or requires bridging factors not confirmed with purified proteins","In vivo relevance of K134-specific ubiquitination not tested"]},{"year":2022,"claim":"Genetic separation of TLR9 into three functional modes—ligand/MyD88-independent scaffold, ligand-dependent/MyD88-independent regulatory, and MyD88-dependent proinflammatory—overturned the linear receptor-signaling model and showed that TLR9's protective role in lupus operates via a B cell-intrinsic scaffold function.","evidence":"TLR9 K51E (no ligand binding) and P915H (no MyD88 recruitment) knockin alleles in lupus-prone mice with bone marrow chimeras","pmids":["36151396"],"confidence":"High","gaps":["Molecular partners for the scaffold function not identified","Whether scaffold function involves other TIR-domain interactions unknown"]},{"year":2024,"claim":"Identification of a DHHC3/PPT1-mediated palmitoylation–depalmitoylation cycle on TLR9 C258/C265 that controls UNC93B1 release and signaling output provided the first lipid-modification mechanism governing TLR9 endosomal trafficking and activation.","evidence":"Mass spectrometry palmitoylation site mapping, C258/C265 mutagenesis, PPT1 KO/inhibition, DHHC3 manipulation with cytokine readouts in vivo and in vitro","pmids":["38169466"],"confidence":"High","gaps":["Whether other palmitoyl-acyltransferases contribute redundantly not excluded","Structural consequences of palmitoylation on TLR9–UNC93B1 interface not resolved"]},{"year":2024,"claim":"Discovery that learning-induced DNA damage activates neuronal TLR9 for memory formation, linking TLR9 to centrosome function and ciliogenesis in neurons, opened an entirely non-immune role for TLR9 in cognitive processes.","evidence":"Neuron-specific Tlr9 knockdown impairing contextual fear memory; gene profiling showing centrosome, DNA repair, and perineuronal net pathways","pmids":["38538785"],"confidence":"Medium","gaps":["Whether endogenous nuclear DNA fragments are the physiological TLR9 ligand in neurons is unconfirmed","Mechanism linking TLR9 to centrosome function not characterized","Single study, not independently replicated"]},{"year":null,"claim":"Key unresolved questions include the identity of molecular partners mediating TLR9's MyD88-independent scaffold function, the structural basis of compartment-specific signaling complex assembly, and whether neuronal and cardiomyocyte TLR9 functions use the same or distinct ligand-processing and trafficking machinery as immune cells.","evidence":"","pmids":[],"confidence":"Low","gaps":["Scaffold function partners unidentified","No high-resolution structure of full-length TLR9 in complex with signaling adaptors","Endogenous ligands in non-immune contexts not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,2,12]},{"term_id":"GO:0140299","term_label":"molecular sensor activity","supporting_discovery_ids":[2,13]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[19]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,10,18]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[1,7,13,15]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[7,9,15,20]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[20]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,2,4,7,12,13,15,16,19]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,7,8,11,16,19]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,17,22]}],"complexes":["TLR9–UNC93B1 trafficking complex","TLR9–MyD88–IRAK1–TRAF6 myddosome"],"partners":["MYD88","UNC93B1","IRAK1","TRAF6","CD82","ZDHHC3","PPT1","LAMP5"],"other_free_text":[]},"mechanistic_narrative":"TLR9 is an endosomal pattern recognition receptor that detects unmethylated CpG DNA and RNA:DNA hybrids to initiate innate immune signaling, with additional non-canonical roles in stress tolerance and neuronal function. At steady state TLR9 resides in the ER and, upon ligand uptake, translocates to endolysosomes where it directly binds CpG DNA at acidic pH; this trafficking requires UNC93B1, proteolytic processing by cathepsins, and a palmitoylation–depalmitoylation cycle mediated by DHHC3 and PPT1 that controls UNC93B1 release and downstream signaling output [PMID:14716310, PMID:23241879, PMID:38169466]. The signaling outcome is compartment-determined: TLR9 activation in early endosomes drives IFN-α production whereas activation in late lysosomes drives NF-κB–dependent TNF responses, with accessory proteins BAD-LAMP, CD82, CD32, and Dectin-1 directing TLR9 to specific compartments [PMID:16864658, PMID:29030552, PMID:15668740, PMID:26829985]. Genetic dissection in lupus-prone mice revealed that TLR9 possesses a MyD88-independent scaffold function that is B cell-intrinsic and protective against autoimmunity, separable from its ligand-dependent proinflammatory signaling [PMID:36151396]."},"prefetch_data":{"uniprot":{"accession":"Q9NR96","full_name":"Toll-like receptor 9","aliases":[],"length_aa":1032,"mass_kda":115.9,"function":"Key component of innate and adaptive immunity (PubMed:14716310). TLRs (Toll-like receptors) control host immune response against pathogens through recognition of molecular patterns specific to microorganisms (PubMed:14716310). TLR9 is a nucleotide-sensing TLR which is activated by unmethylated cytidine-phosphate-guanosine (CpG) dinucleotides (PubMed:14716310). Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:11564765, PubMed:17932028). Also acts via ADCY7, leading to cyclic di-AMP (c-di-AMP) synthesis and activation of the NLRP3 inflammasome (By similarity). Plays a role in defense against systemic mouse cytomegalovirus infection (By similarity). Controls lymphocyte response to Helicobacter infection (By similarity). Upon CpG stimulation, induces B-cell proliferation, activation, survival and antibody production (PubMed:23857366)","subcellular_location":"Endoplasmic reticulum membrane; Early endosome membrane; Lysosome; Cytoplasmic vesicle, phagosome; Golgi apparatus membrane","url":"https://www.uniprot.org/uniprotkb/Q9NR96/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TLR9","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TLR9","total_profiled":1310},"omim":[{"mim_id":"618488","title":"PHOSPHOLIPASE D FAMILY, MEMBER 4; PLD4","url":"https://www.omim.org/entry/618488"},{"mim_id":"616345","title":"IMMUNODEFICIENCY 39, SUSCEPTIBILITY TO VIRAL INFECTIONS; IMD39","url":"https://www.omim.org/entry/616345"},{"mim_id":"616005","title":"IMMUNODEFICIENCY 36 WITH LYMPHOPROLIFERATION; IMD36","url":"https://www.omim.org/entry/616005"},{"mim_id":"615806","title":"SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 4; SLC15A4","url":"https://www.omim.org/entry/615806"},{"mim_id":"615698","title":"PHOSPHOLIPASE D FAMILY, MEMBER 3; PLD3","url":"https://www.omim.org/entry/615698"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":5.6}],"url":"https://www.proteinatlas.org/search/TLR9"},"hgnc":{"alias_symbol":["CD289"],"prev_symbol":[]},"alphafold":{"accession":"Q9NR96","domains":[{"cath_id":"3.80.10.10","chopping":"30-167","consensus_level":"medium","plddt":93.0464,"start":30,"end":167},{"cath_id":"3.80.10.10","chopping":"320-428","consensus_level":"medium","plddt":94.5033,"start":320,"end":428},{"cath_id":"3.40.50.10140","chopping":"871-1023","consensus_level":"high","plddt":82.5775,"start":871,"end":1023}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NR96","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NR96-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NR96-F1-predicted_aligned_error_v6.png","plddt_mean":86.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TLR9","jax_strain_url":"https://www.jax.org/strain/search?query=TLR9"},"sequence":{"accession":"Q9NR96","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NR96.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NR96/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NR96"}},"corpus_meta":[{"pmid":"15668740","id":"PMC_15668740","title":"Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.","date":"2005","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/15668740","citation_count":666,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19211030","id":"PMC_19211030","title":"Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists.","date":"2009","source":"Advanced drug delivery reviews","url":"https://pubmed.ncbi.nlm.nih.gov/19211030","citation_count":453,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26808498","id":"PMC_26808498","title":"Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9.","date":"2016","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/26808498","citation_count":401,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17476348","id":"PMC_17476348","title":"Development of TLR9 agonists for cancer therapy.","date":"2007","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/17476348","citation_count":347,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18262306","id":"PMC_18262306","title":"TLR9 as a key receptor for the recognition of DNA.","date":"2008","source":"Advanced drug delivery reviews","url":"https://pubmed.ncbi.nlm.nih.gov/18262306","citation_count":320,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18176597","id":"PMC_18176597","title":"Toll-like receptor 9 (TLR9) agonists in the treatment of cancer.","date":"2008","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/18176597","citation_count":318,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21439959","id":"PMC_21439959","title":"TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis.","date":"2011","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/21439959","citation_count":241,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21129170","id":"PMC_21129170","title":"Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis.","date":"2010","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21129170","citation_count":194,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29632021","id":"PMC_29632021","title":"Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency.","date":"2018","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/29632021","citation_count":169,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20498358","id":"PMC_20498358","title":"Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20498358","citation_count":167,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22434514","id":"PMC_22434514","title":"TLR7 and TLR9 in SLE: when sensing self goes wrong.","date":"2012","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/22434514","citation_count":163,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38169466","id":"PMC_38169466","title":"Cyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38169466","citation_count":151,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27795867","id":"PMC_27795867","title":"The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis.","date":"2016","source":"International journal of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/27795867","citation_count":144,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24514026","id":"PMC_24514026","title":"RNA:DNA hybrids are a novel molecular pattern sensed by TLR9.","date":"2014","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/24514026","citation_count":134,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22046272","id":"PMC_22046272","title":"Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22046272","citation_count":130,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25600358","id":"PMC_25600358","title":"DNase II-dependent DNA digestion is required for DNA sensing by TLR9.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25600358","citation_count":122,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20978888","id":"PMC_20978888","title":"Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.","date":"2010","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/20978888","citation_count":121,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18760996","id":"PMC_18760996","title":"Role of TLR9 in hepatic stellate cells and experimental liver fibrosis.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18760996","citation_count":117,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25930080","id":"PMC_25930080","title":"TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration.","date":"2015","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25930080","citation_count":115,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30900780","id":"PMC_30900780","title":"Below the surface: The inner lives of TLR4 and TLR9.","date":"2019","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/30900780","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21990957","id":"PMC_21990957","title":"Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma.","date":"2011","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/21990957","citation_count":107,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18652679","id":"PMC_18652679","title":"Comparison of human B cell activation by TLR7 and TLR9 agonists.","date":"2008","source":"BMC immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18652679","citation_count":103,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24169824","id":"PMC_24169824","title":"Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24169824","citation_count":92,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29880709","id":"PMC_29880709","title":"Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells.","date":"2018","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/29880709","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15678105","id":"PMC_15678105","title":"DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15678105","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14552833","id":"PMC_14552833","title":"Differential signaling by CpG DNA in DCs and B cells: not just TLR9.","date":"2003","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14552833","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20560798","id":"PMC_20560798","title":"Targeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses.","date":"2010","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/20560798","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17145922","id":"PMC_17145922","title":"TLR9 and the recognition of self and non-self nucleic acids.","date":"2006","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17145922","citation_count":85,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32191633","id":"PMC_32191633","title":"B cell-intrinsic TLR9 expression is protective in murine lupus.","date":"2020","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/32191633","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19894778","id":"PMC_19894778","title":"CpG oligodeoxynucleotides as TLR9 agonists: therapeutic applications in cancer.","date":"2009","source":"BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/19894778","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31170232","id":"PMC_31170232","title":"PINK1 attenuates mtDNA release in alveolar epithelial cells and TLR9 mediated profibrotic responses.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31170232","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23479602","id":"PMC_23479602","title":"TLR9 mediates cellular protection by modulating energy metabolism in cardiomyocytes and neurons.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23479602","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20623989","id":"PMC_20623989","title":"CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma.","date":"2010","source":"BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/20623989","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19846276","id":"PMC_19846276","title":"Emerging roles of TLR7 and TLR9 in murine SLE.","date":"2009","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/19846276","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30630901","id":"PMC_30630901","title":"Chronic TLR7 and TLR9 signaling drives anemia via differentiation of specialized hemophagocytes.","date":"2019","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/30630901","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15294971","id":"PMC_15294971","title":"Transcriptional regulation of the human TLR9 gene.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15294971","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33643304","id":"PMC_33643304","title":"The Trinity of cGAS, TLR9, and ALRs Guardians of the Cellular Galaxy Against Host-Derived Self-DNA.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33643304","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22893852","id":"PMC_22893852","title":"TLR9 is important for protection against intestinal damage and for intestinal repair.","date":"2012","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/22893852","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19299739","id":"PMC_19299739","title":"Bacterial DNA activates endothelial cells and promotes neutrophil adherence through TLR9 signaling.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19299739","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18817866","id":"PMC_18817866","title":"A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation.","date":"2008","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/18817866","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15652668","id":"PMC_15652668","title":"TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.","date":"2005","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/15652668","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24993857","id":"PMC_24993857","title":"TLR9 and BAFF: their expression in patients with IgA nephropathy.","date":"2014","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/24993857","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38538785","id":"PMC_38538785","title":"Formation of memory assemblies through the DNA-sensing TLR9 pathway.","date":"2024","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/38538785","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25681333","id":"PMC_25681333","title":"Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25681333","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29030552","id":"PMC_29030552","title":"BAD-LAMP controls TLR9 trafficking and signalling in human plasmacytoid dendritic cells.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29030552","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12467249","id":"PMC_12467249","title":"Bacterial CpG-DNA licenses TLR9.","date":"2002","source":"Current topics in microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12467249","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25047528","id":"PMC_25047528","title":"TLR9 is critical for glioma stem cell maintenance and targeting.","date":"2014","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/25047528","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16818370","id":"PMC_16818370","title":"TLR9 in health and disease.","date":"2006","source":"International reviews of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16818370","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27538577","id":"PMC_27538577","title":"TLR2 and TLR9 modulate enteric nervous system inflammatory responses to lipopolysaccharide.","date":"2016","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/27538577","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20935225","id":"PMC_20935225","title":"Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma.","date":"2010","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20935225","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20442858","id":"PMC_20442858","title":"Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.","date":"2010","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/20442858","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24612681","id":"PMC_24612681","title":"Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation.","date":"2014","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24612681","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22847512","id":"PMC_22847512","title":"Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer.","date":"2012","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/22847512","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36151396","id":"PMC_36151396","title":"Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus.","date":"2022","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36151396","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17057215","id":"PMC_17057215","title":"Homeostatic effects of TLR9 signaling in experimental colitis.","date":"2006","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17057215","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15588423","id":"PMC_15588423","title":"Mechanisms of TLR9 activation.","date":"2004","source":"Journal of endotoxin research","url":"https://pubmed.ncbi.nlm.nih.gov/15588423","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31703913","id":"PMC_31703913","title":"TLR9 signaling mediates adaptive immunity following systemic AAV gene therapy.","date":"2019","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31703913","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22357629","id":"PMC_22357629","title":"Lymphotoxin β receptor activation on macrophages induces cross-tolerance to TLR4 and TLR9 ligands.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22357629","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33831324","id":"PMC_33831324","title":"Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy.","date":"2021","source":"Expert review of anticancer therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33831324","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26829985","id":"PMC_26829985","title":"Dectin-1 Controls TLR9 Trafficking to Phagosomes Containing β-1,3 Glucan.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/26829985","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33584545","id":"PMC_33584545","title":"TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism.","date":"2021","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/33584545","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18950591","id":"PMC_18950591","title":"Redundant role of TLR9 for anti-Candida host defense.","date":"2008","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/18950591","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26567289","id":"PMC_26567289","title":"TLR7 and TLR9 ligands regulate antigen presentation by macrophages.","date":"2015","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26567289","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34215697","id":"PMC_34215697","title":"Matrix lumican endocytosed by immune cells controls receptor ligand trafficking to promote TLR4 and restrict TLR9 in sepsis.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34215697","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22423970","id":"PMC_22423970","title":"Cofactors required for TLR7- and TLR9-dependent innate immune responses.","date":"2012","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/22423970","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35963302","id":"PMC_35963302","title":"TLR9: A friend or a foe.","date":"2022","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35963302","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28151089","id":"PMC_28151089","title":"Role of TLR9 in Oncogenic Virus-Produced Cancer.","date":"2017","source":"Viral immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28151089","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25248338","id":"PMC_25248338","title":"The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis.","date":"2014","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/25248338","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20375564","id":"PMC_20375564","title":"Attenuated activation of macrophage TLR9 by DNA from virulent mycobacteria.","date":"2008","source":"Journal of innate immunity","url":"https://pubmed.ncbi.nlm.nih.gov/20375564","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18641342","id":"PMC_18641342","title":"Protein kinase D1: a new component in TLR9 signaling.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18641342","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36835307","id":"PMC_36835307","title":"Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36835307","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23816930","id":"PMC_23816930","title":"Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer.","date":"2013","source":"The Journal of international medical research","url":"https://pubmed.ncbi.nlm.nih.gov/23816930","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28803064","id":"PMC_28803064","title":"High-glucose induces tau hyperphosphorylation through activation of TLR9-P38MAPK pathway.","date":"2017","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28803064","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26914888","id":"PMC_26914888","title":"JNK-TLR9 signal pathway mediates allergic airway inflammation through suppressing melatonin biosynthesis.","date":"2016","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/26914888","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18071654","id":"PMC_18071654","title":"TLR9-mediated recognition of DNA.","date":"2008","source":"Handbook of experimental pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18071654","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23241879","id":"PMC_23241879","title":"Cell-specific TLR9 trafficking in primary APCs of transgenic TLR9-GFP mice.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23241879","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25400780","id":"PMC_25400780","title":"Helicobacter pylori regulates TLR4 and TLR9 during gastric carcinogenesis.","date":"2014","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25400780","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24647486","id":"PMC_24647486","title":"Functional expression of TLR9 in esophageal cancer.","date":"2014","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/24647486","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34084165","id":"PMC_34084165","title":"Self-DNA Sensing by cGAS-STING and TLR9 in Autoimmunity: Is the Cytoskeleton in Control?","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34084165","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25098409","id":"PMC_25098409","title":"TLR9 ligands induce S100A8 in macrophages via a STAT3-dependent pathway which requires IL-10 and PGE2.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25098409","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28102569","id":"PMC_28102569","title":"Human β-defensin 3 increases the TLR9-dependent response to bacterial DNA.","date":"2017","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28102569","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17341193","id":"PMC_17341193","title":"DNA motifs suppressing TLR9 responses.","date":"2006","source":"Critical reviews in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17341193","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33512408","id":"PMC_33512408","title":"TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/33512408","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29433938","id":"PMC_29433938","title":"B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors.","date":"2018","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29433938","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21086718","id":"PMC_21086718","title":"The expression of TLR9 in human cutaneous leishmaniasis is associated with granuloma.","date":"2010","source":"Parasite immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21086718","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28757323","id":"PMC_28757323","title":"Exogenous administration of mitochondrial DNA promotes ischemia reperfusion injury via TLR9-p38 MAPK pathway.","date":"2017","source":"Regulatory toxicology and pharmacology : RTP","url":"https://pubmed.ncbi.nlm.nih.gov/28757323","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31851971","id":"PMC_31851971","title":"HSV-1/TLR9-Mediated IFNβ and TNFα Induction Is Mal-Dependent in Macrophages.","date":"2019","source":"Journal of innate immunity","url":"https://pubmed.ncbi.nlm.nih.gov/31851971","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35848907","id":"PMC_35848907","title":"Insights into innate immune activation via PS-ASO-protein-TLR9 interactions.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/35848907","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30662369","id":"PMC_30662369","title":"The Effect and Mechanism of TLR9/KLF4 in FFA-Induced Adipocyte Inflammation.","date":"2018","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/30662369","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21115235","id":"PMC_21115235","title":"Cell-specific expression of TLR9 isoforms in inflammation.","date":"2010","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/21115235","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25616954","id":"PMC_25616954","title":"TLR9 gene region polymorphisms and susceptibility to tuberculosis in Vietnam.","date":"2015","source":"Tuberculosis (Edinburgh, Scotland)","url":"https://pubmed.ncbi.nlm.nih.gov/25616954","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27537371","id":"PMC_27537371","title":"Computational Discovery and Experimental Confirmation of TLR9 Receptor Antagonist Leads.","date":"2016","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/27537371","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35419609","id":"PMC_35419609","title":"Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation.","date":"2022","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35419609","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37365634","id":"PMC_37365634","title":"Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma.","date":"2023","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/37365634","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31408613","id":"PMC_31408613","title":"CD82 controls CpG-dependent TLR9 signaling.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/31408613","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38537697","id":"PMC_38537697","title":"Epstein-Barr virus suppresses N6-methyladenosine modification of TLR9 to promote immune evasion.","date":"2024","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38537697","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27610009","id":"PMC_27610009","title":"Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis?","date":"2016","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/27610009","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29038250","id":"PMC_29038250","title":"Inhibition of IRAK1 Ubiquitination Determines Glucocorticoid Sensitivity for TLR9-Induced Inflammation in Macrophages.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/29038250","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28131238","id":"PMC_28131238","title":"TLR9 and its signaling pathway in multiple sclerosis.","date":"2016","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28131238","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24726642","id":"PMC_24726642","title":"TLR9 agonist regulates angiogenesis and inhibits corneal neovascularization.","date":"2014","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24726642","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11130078","id":"PMC_11130078","title":"A Toll-like receptor recognizes bacterial DNA.","date":"2000","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/11130078","citation_count":4949,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11970999","id":"PMC_11970999","title":"Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11970999","citation_count":1520,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11561001","id":"PMC_11561001","title":"Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens.","date":"2001","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11561001","citation_count":1457,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9435236","id":"PMC_9435236","title":"A family of human receptors structurally related to Drosophila Toll.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9435236","citation_count":1291,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23974872","id":"PMC_23974872","title":"Genome-wide association analysis identifies 13 new risk loci for schizophrenia.","date":"2013","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23974872","citation_count":1192,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16979567","id":"PMC_16979567","title":"Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors.","date":"2006","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/16979567","citation_count":1139,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14716310","id":"PMC_14716310","title":"TLR9 signals after translocating from the ER to CpG DNA in the lysosome.","date":"2004","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14716310","citation_count":1069,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21926972","id":"PMC_21926972","title":"Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4.","date":"2011","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21926972","citation_count":1068,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15723075","id":"PMC_15723075","title":"Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7.","date":"2005","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15723075","citation_count":981,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15356140","id":"PMC_15356140","title":"Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15356140","citation_count":973,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16230478","id":"PMC_16230478","title":"Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.","date":"2005","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16230478","citation_count":739,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12560217","id":"PMC_12560217","title":"A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12560217","citation_count":529,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21398612","id":"PMC_21398612","title":"Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21398612","citation_count":477,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17128265","id":"PMC_17128265","title":"Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells.","date":"2006","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17128265","citation_count":471,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12925853","id":"PMC_12925853","title":"SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling.","date":"2003","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12925853","citation_count":467,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11564765","id":"PMC_11564765","title":"Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11564765","citation_count":443,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20100933","id":"PMC_20100933","title":"Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20100933","citation_count":436,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15307186","id":"PMC_15307186","title":"Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.","date":"2004","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15307186","citation_count":408,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12660731","id":"PMC_12660731","title":"The role of PI3K in immune cells.","date":"2003","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12660731","citation_count":391,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11909637","id":"PMC_11909637","title":"Toll-like receptors as adjuvant receptors.","date":"2002","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/11909637","citation_count":359,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11022119","id":"PMC_11022119","title":"Three novel mammalian toll-like receptors: gene structure, expression, and evolution.","date":"2000","source":"European cytokine network","url":"https://pubmed.ncbi.nlm.nih.gov/11022119","citation_count":357,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18946062","id":"PMC_18946062","title":"Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.","date":"2008","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18946062","citation_count":345,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11022120","id":"PMC_11022120","title":"Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9.","date":"2000","source":"European cytokine network","url":"https://pubmed.ncbi.nlm.nih.gov/11022120","citation_count":321,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16864658","id":"PMC_16864658","title":"Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.","date":"2006","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16864658","citation_count":311,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20559388","id":"PMC_20559388","title":"TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus.","date":"2010","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/20559388","citation_count":301,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18806803","id":"PMC_18806803","title":"Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections.","date":"2008","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18806803","citation_count":300,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46746,"output_tokens":7089,"usd":0.123286},"stage2":{"model":"claude-opus-4-6","input_tokens":10879,"output_tokens":4317,"usd":0.24348},"total_usd":0.712439,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":60208,"output_tokens":5741,"usd":0.13337},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9632,"output_tokens":3735,"usd":0.212303}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"TLR9 resides in the endoplasmic reticulum at steady state and translocates to CpG-DNA-containing endosomal/tubular lysosomal compartments upon stimulation, where it binds DNA and initiates signaling; this trafficking is required for TLR9 activation.\",\n      \"method\": \"Subcellular fractionation, fluorescence microscopy of GFP-tagged TLR9 and fluorescent CpG-DNA in human pDCs\",\n      \"journal\": \"Journal of endotoxin research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct live-cell and fixed imaging with functional consequence, consistent with multiple subsequent studies\",\n      \"pmids\": [\"15588423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DNA-containing immune complexes from lupus serum activate plasmacytoid DCs through cooperative interaction between FcγRIIa (CD32) and TLR9: CD32 delivers immune complexes to intracellular lysosomes containing TLR9, triggering a signaling cascade leading to DC activation.\",\n      \"method\": \"Co-localization imaging, functional assays with CD32+/- pDC sorting, antibody blocking, knockout/deficient cell studies\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal functional experiments with cell sorting, co-localization, and antibody blocking; replicated in concept across multiple lupus studies\",\n      \"pmids\": [\"15668740\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Human TLR9 gene transcription is regulated by four cis-acting elements (cAMP response element, 5'-PU box, 3'-PU box, C/EBP site) interacting with CREB1, Ets2, Elf1, Elk1, and C/EBPα transcription factors; CpG DNA suppresses TLR9 transcription via c-Jun and NF-κB p65.\",\n      \"method\": \"Reporter gene analysis and EMSA in RPMI 8226 myeloma cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (reporter + EMSA) in a single lab\",\n      \"pmids\": [\"15294971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TLR9 stimulation activates Protein Kinase D1 (PKD1) in macrophages via a pathway dependent on endosomal pH, TLR9, MyD88, and IRAK1; PKD1 interacts with the TLR9/MyD88/IRAK/TRAF6 complex and is required for NF-κB and MAPK activation and cytokine expression downstream of CpG-B DNA.\",\n      \"method\": \"Co-immunoprecipitation, PKD1 knockdown (siRNA), kinase activity assays, pharmacological inhibition of endosomal acidification in macrophages\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, knockdown with phenotypic rescue, and pharmacological validation in primary macrophages\",\n      \"pmids\": [\"18641342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Cell-specific proteolytic processing of TLR9 is required for its activation in primary APCs; cleavage kinetics and cathepsin requirements differ between macrophages (cathepsins L and S) and B cells (cathepsin L alone); UNC93B1 expression level tightly correlates with TLR9 cleavage.\",\n      \"method\": \"Transgenic TLR9-GFP mice, live imaging, pharmacological cathepsin inhibition, UNC93B1 3d mutant comparison, fluorescence microscopy\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — in vivo transgenic model, multiple inhibitor experiments, genetic mutant controls across three primary cell types\",\n      \"pmids\": [\"23241879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DNase II digestion of DNA in endolysosomes is required for TLR9 activation by CpG-A and bacterial genomic DNA; DNase II cleaves CpG-A from 20-mer to 11-12-mer fragments, and the 3'-11-mer CpG-A fragment can activate DNase II-deficient DCs, demonstrating that TLR9 responds to specific DNA fragments generated by DNase II.\",\n      \"method\": \"DNase II-deficient dendritic cells, enzymatically inactive DNase II mutant rescue, co-localization with LAMP-2+ lysosomes, synthetic fragment stimulation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzyme activity, genetic knockout, inactive mutant controls, and functional fragment assays\",\n      \"pmids\": [\"25600358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RNA:DNA hybrids are a novel molecular pattern sensed by TLR9 in a MyD88-dependent manner, inducing pro-inflammatory cytokines and type I interferons in dendritic cells.\",\n      \"method\": \"MyD88-deficient cells, TLR9 knockout cells, cytokine production assays, genetic epistasis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with KO cells and MyD88-deficient cells, multiple readouts\",\n      \"pmids\": [\"24514026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BAD-LAMP (LAMP5) controls TLR9 trafficking to LAMP1+ late endosomes in human plasmacytoid DCs, directing NF-κB activation and TNF production; an inducible VAMP3+/LAMP2+/LAMP1- compartment mediates type I interferon expression upon TLR9 activation, and BAD-LAMP silencing enhances TLR9 retention in this interferon-producing compartment.\",\n      \"method\": \"siRNA silencing, immunofluorescence co-localization, cytokine production assays, endosomal compartment characterization in primary human pDCs\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockdown with compartment-specific trafficking assays and functional cytokine readouts in primary cells\",\n      \"pmids\": [\"29030552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TLR9 undergoes a cycle of S-palmitoylation and depalmitoylation: DHHC3 palmitoylates TLR9 at C258 and C265 in the Golgi, regulating its trafficking to endosomes, while PPT1 removes S-palmitoylation from TLR9 in lysosomes, facilitating TLR9 release from UNC93B1 and promoting IFNα secretion by pDCs.\",\n      \"method\": \"Mass spectrometry identification of palmitoylation sites, biochemical palmitoylation assays, PPT1/DHHC3 genetic deficiency and chemical inhibition, co-immunoprecipitation with UNC93B1\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mass spectrometry plus site-directed mutagenesis plus genetic/chemical perturbation across multiple cell types\",\n      \"pmids\": [\"38169466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Dectin-1 controls TLR9 trafficking to phagosomes containing β-1,3 glucan via spleen tyrosine kinase (Syk) activation; phagosomal acidification is required for TLR9 accumulation, and Dectin-1 regulates TLR9-dependent gene expression.\",\n      \"method\": \"Fluorescence microscopy of TLR9 redistribution, pharmacological inhibition of acidification, Syk inhibition, β-1,3 glucan bead phagocytosis assays, gene expression analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological and genetic perturbations with direct imaging of TLR9 trafficking\",\n      \"pmids\": [\"26829985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CD82 (a tetraspanin) associates with TLR9 in the ER and post-ER compartments of macrophages, is essential for TLR9-dependent myddosome formation in response to CpG, and modulates TLR9-dependent NF-κB nuclear translocation and inflammatory cytokine production.\",\n      \"method\": \"Co-immunoprecipitation, confocal imaging, myddosome assembly assay, NF-κB translocation assay, CD82-deficient macrophages\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, knockout cells, and multiple functional readouts\",\n      \"pmids\": [\"31408613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HRS (hepatocyte growth factor-regulated tyrosine kinase substrate) is necessary for ubiquitin-dependent TLR9 targeting to the endolysosome, identified through genome-wide RNAi screening.\",\n      \"method\": \"Genome-wide RNAi screen, functional validation of TLR9 endolysosomal targeting\",\n      \"journal\": \"Cell host & microbe\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide screen with mechanistic follow-up, single lab\",\n      \"pmids\": [\"22423970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DNA-PKcs, not TLR9, is the primary mediator of CpG-DNA-induced Akt activation; DNA-PK directly phosphorylates and activates Akt in vitro, associates with Akt upon CpG-DNA stimulation, and triggers transient nuclear translocation of Akt in BMDMs. TLR9 loss has minimal effect on Akt activation by CpG-DNA.\",\n      \"method\": \"DNA-PKcs knockout macrophages, in vitro kinase assay with purified DNA-PK and recombinant Akt, Co-immunoprecipitation, subcellular fractionation\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified proteins plus genetic knockout plus Co-IP\",\n      \"pmids\": [\"15678105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TLR9 stimulation in cardiomyocytes activates AMPK by reducing energy substrates and increasing the AMP/ATP ratio, leading to increased stress tolerance against hypoxia without inducing canonical inflammatory responses; UNC93B1 acts as a pivotal switch regulating subcellular localization of TLR9 to determine whether inflammatory or metabolic responses are elicited.\",\n      \"method\": \"TLR9 stimulation in primary cardiomyocytes and neurons, AMPK activity assays, UNC93B1 expression comparison between cardiomyocytes and macrophages, gene expression profiling\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean functional assays in primary cells with pathway identification, single lab\",\n      \"pmids\": [\"23479602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TLR9 stimulation in hepatic stellate cells (HSC) by CpG induces MCP-1 expression; TLR9-deficient mice show reduced hepatic MCP-1 and collagen expression, less alpha-SMA (HSC activation marker), and reduced fibrosis after bile duct ligation.\",\n      \"method\": \"TLR9-/- mouse model, primary HSC isolation, bile duct ligation, gene and protein expression analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with in vivo and in vitro validation, single lab\",\n      \"pmids\": [\"18760996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Mitochondrial DNA (mtDNA) released from hepatocytes in microparticles is a ligand for TLR9 in NASH; TLR9 on lysozyme-expressing (macrophage lineage) cells is required for NASH development in response to high-fat diet, as demonstrated by conditional deletion.\",\n      \"method\": \"TLR9 conditional knockout mice, plasma mtDNA measurement, microparticle fractionation and TLR9 activation assays, TLR9 antagonist treatment\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO, ex vivo TLR9 activation assays with fractionated plasma, TLR9 antagonist rescue; multiple orthogonal methods\",\n      \"pmids\": [\"26808498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Dengue virus infection induces release of mitochondrial DNA into the cytosol via ROS generation and inflammasome activation, which then activates TLR9 signaling pathways in human dendritic cells to produce interferons; DENV disrupts TFAM-mtDNA association and activates mitochondrial permeability transition pores.\",\n      \"method\": \"TLR9 knockdown, cGAS knockdown, Tlr9-knockout mouse BMDCs, mtDNA detection assays, ROS inhibition\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown, genetic KO, and multiple mechanistic pathway assays across human and mouse cells\",\n      \"pmids\": [\"29880709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Opa1 deficiency in muscle causes mitochondrial DNA release that activates TLR9, leading to NF-κB activation and muscle inflammation in a cell-autonomous manner independent of cell death; blockage or repression of TLR9 prevents NF-κB activation in Opa1-deficient muscle cells.\",\n      \"method\": \"Muscle-specific Opa1 knockout, mtDNA depletion, TLR9 repression/blockage, NF-κB activation assays in primary muscle cells\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic models, mtDNA depletion, TLR9 blockage, multiple orthogonal readouts\",\n      \"pmids\": [\"29632021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Glucocorticoid receptor (GR) physically interacts with IRAK1 upon TLR9 engagement, interfering with β-TrCP-IRAK1 interaction and preventing K48-linked ubiquitination of IRAK1 at Lys134, which is required for NF-κB and MAPK activation downstream of TLR9 (but not TLR4).\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis of IRAK1 Lys134, GR knockout macrophages, ubiquitination assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — Co-IP, mutagenesis, genetic KO, and ubiquitination assays establishing a TLR9-specific mechanism\",\n      \"pmids\": [\"29038250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Bruton's tyrosine kinase (BTK) mediates human DC responses to TLR9 stimulation: XLA patients lacking functional BTK show completely impaired TLR9-dependent DC activation (CD86, CD83, CD80, HLA-DR upregulation, IL-6, IL-12, TNFα, IL-10 production) and STAT1/3 upregulation; ibrutinib (BTK inhibitor) recapitulates this defect.\",\n      \"method\": \"DCs from XLA patients vs. healthy donors, BTK inhibitor (ibrutinib) treatment, cytokine ELISA, surface marker flow cytometry\",\n      \"journal\": \"The Journal of allergy and clinical immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — natural human loss-of-function, pharmacological inhibition, multiple readouts\",\n      \"pmids\": [\"24612681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TLR9 has distinct functional modes in lupus: (1) a ligand- and MyD88-independent 'scaffold' protective function; (2) ligand-dependent but MyD88-independent regulatory signaling; and (3) MyD88-mediated proinflammatory signaling. B cell-intrinsic MyD88-independent TLR9 regulatory roles restrain differentiation into pathogenic age-associated B cells and plasmablasts.\",\n      \"method\": \"TLR9 point mutants (TLR9K51E and TLR9P915H) in MRL/lpr lupus-prone mice, mixed bone marrow chimeras, disease phenotyping\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — structure-function point mutants in vivo with bone marrow chimeras and epistasis in genetic lupus model\",\n      \"pmids\": [\"36151396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"B cell-intrinsic TLR9 expression protects from lupus nephritis; conditional B cell-specific Tlr9 deletion exacerbates nephritis while eliminating anti-nucleosome antibodies, whereas B cell-specific TLR9 overexpression ameliorates nephritis.\",\n      \"method\": \"Conditional Tlr9 deletion and overexpression alleles crossed to lupus-prone mice, cell-type-specific analysis of disease\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain- and loss-of-function in B cells in vivo with clear disease phenotype\",\n      \"pmids\": [\"32191633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TLR9-deficient autoreactive B cells show enhanced autonomous survival/proliferation and preferentially differentiate toward plasma cells (increased CD138, IRF4) compared to WT or TLR7-deficient B cells, demonstrating that TLR9 intrinsically limits autoreactive B cell plasma cell differentiation.\",\n      \"method\": \"BCR/TLR co-engagement proliferation assay, in vitro comparison of WT, TLR9-/-, TLR7-/- B cells, in vivo autoantibody-producing cell quantification\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct comparison of genetic knockouts with defined in vitro and in vivo readouts\",\n      \"pmids\": [\"25681333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TLR9 activation via CpG induces Lox-1 and Nox1 expression in macrophages via the TLR9-p38 MAPK and NF-κB pathways, promoting foam cell formation; Nox1-mediated ROS generation is required for CpG ODN-induced foam cell formation.\",\n      \"method\": \"siRNA knockdown of Nox1, antioxidant treatment, MAPK inhibitors, NF-κB inhibitors, foam cell formation assay in Raw264.7 and primary macrophages\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA, pharmacological inhibition, multiple pathway readouts in one lab\",\n      \"pmids\": [\"18817866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TLR9 in human endothelial cells (HUVECs) recognizes unmethylated CpG motifs in bacterial DNA, triggering IκB-α phosphorylation and NF-κB-mediated upregulation of ICAM-1 and E-selectin, independently of MAPK signaling; this requires endosomal acidification and leads to enhanced neutrophil adhesion via CD18 and E-selectin.\",\n      \"method\": \"Pharmacological inhibition of endosomal acidification, NF-κB inhibition, TLR9 inhibitory oligonucleotide, neutrophil adhesion assay under flow\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection with multiple pathway readouts and functional adhesion assay\",\n      \"pmids\": [\"19299739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Learning-induced double-stranded DNA breaks in hippocampal CA1 neurons activate TLR9 signaling, which is essential for centrosome function (DNA damage repair, ciliogenesis, perineuronal net formation) and memory circuit formation; neuron-specific Tlr9 knockdown impairs memory and alters gene expression in CA1 neuron clusters.\",\n      \"method\": \"Neuron-specific Tlr9 knockdown, contextual fear conditioning, imaging of dsDNA breaks and TLR9 co-localization with centrosomal repair complexes, perineuronal net analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific knockdown, behavioral readout, imaging-based mechanistic chain\",\n      \"pmids\": [\"38538785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"EBV downregulates TLR9 m6A modification by promoting METTL3 protein degradation via K48-linked ubiquitination mediated by Epstein-Barr nuclear antigen 1 (EBNA1), reducing TLR9 mRNA stability; YTHDF1 is an m6A reader of TLR9 that promotes TLR9 mRNA translation.\",\n      \"method\": \"m6A sequencing/immunoprecipitation, METTL3 knockdown, YTHDF1 identification, ubiquitination assays, EBV infection models\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — m6A mapping, writer/reader identification, ubiquitination mechanism with EBV viral protein, multiple orthogonal assays\",\n      \"pmids\": [\"38537697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PINK1 deficiency in alveolar epithelial cells (AECII) leads to mtDNA oxidation and extracellular release; extracellular mtDNA is recognized by TLR9 via an endocytic-dependent pathway in AECII, triggering TGF-β secretion and profibrotic responses; PINK1 overexpression rescues this.\",\n      \"method\": \"PINK1 knockdown/overexpression in AECII, mtDNA oxidation assays, endocytic inhibition, TLR9 activation assays, TGF-β ELISA\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic gain/loss of function with mechanistic pathway readouts, single lab\",\n      \"pmids\": [\"31170232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Matrix protein lumican restricts TLR9 signaling in macrophages and dendritic cells by sequestering CpG DNA ligand (competing with CD14 for CpG DNA binding), keeping TLR9 away from signal-permissive endolysosomes; lumican-null macrophages show elevated TLR9 in endolysosomes and increased TLR9 responses.\",\n      \"method\": \"Lumican-null mice, Co-localization imaging of lumican with CpG DNA and TLR9, in vitro competition binding assay, cytokine assays\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO, imaging, and in vitro ligand competition assay, single lab\",\n      \"pmids\": [\"34215697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"LTβR activation on macrophages induces TRIM30α, which negatively regulates NF-κB activation downstream of TLR9 signaling, establishing cross-tolerance to TLR9 ligands; macrophage-specific LTβR knockout abrogates this tolerance.\",\n      \"method\": \"siRNA knockdown of TRIM30α, LTβR-conditional knockout mice (LTβRflox/flox × LysM-Cre), in vitro and in vivo TLR9 re-stimulation assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO and siRNA with mechanistic pathway identification, single lab\",\n      \"pmids\": [\"22357629\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TLR9 is an endosomal pattern recognition receptor that traffics from the ER (regulated by UNC93B1 and palmitoylation cycling via DHHC3/PPT1) to endolysosomes, where proteolytic cleavage (by cathepsins L and/or S) generates an active form that binds unmethylated CpG DNA (or RNA:DNA hybrids, oxidized mtDNA) digested by DNase II, then signals through a MyD88/IRAK1/TRAF6/NF-κB axis modulated by accessory proteins (CD82, BTK, PKD1, BAD-LAMP) and regulatory PTMs to produce inflammatory cytokines or type I interferons depending on subcellular compartment and cell type, while also possessing MyD88-independent scaffold functions that restrain autoreactive B cell differentiation in lupus.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"TLR9 is the essential pattern recognition receptor for bacterial CpG DNA; TLR9-deficient mice fail to respond to CpG DNA stimulation, including splenocyte proliferation, inflammatory cytokine production, dendritic cell maturation, and in vivo Th1 responses, establishing TLR9 as the receptor that distinguishes bacterial from self-DNA.\",\n      \"method\": \"TLR9 knockout mice, in vitro stimulation assays, in vivo cytokine measurement\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — foundational KO study with multiple orthogonal readouts, highly replicated across the field\",\n      \"pmids\": [\"11130078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TLR9 resides in the endoplasmic reticulum at steady state and translocates to CpG DNA-containing lysosomal compartments upon ligand uptake, where it co-accumulates with MyD88 and initiates signaling; this established a previously unknown mechanism of immune receptor activation requiring ER-to-lysosome translocation.\",\n      \"method\": \"Fluorescence microscopy, subcellular fractionation, co-localization studies in dendritic cells and macrophages, ligand-binding studies\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple imaging and biochemical approaches in primary cells, independently confirmed\",\n      \"pmids\": [\"14716310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TLR9 binds directly and sequence-specifically to single-stranded unmethylated CpG-DNA at acidic pH (6.5–5.0) matching endosomal/lysosomal conditions; a CpG-DNA binding domain homologous to methyl-CpG-binding proteins was identified, and amino acid substitutions in this region abrogated both CpG-DNA binding and NF-κB activation.\",\n      \"method\": \"Direct binding assays, site-directed mutagenesis, NF-κB reporter assays\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct binding assay combined with mutagenesis and functional readout\",\n      \"pmids\": [\"15307186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Human TLR9 gene transcription is regulated by four cis-acting elements (CRE, 5'-PU box, 3'-PU box, C/EBP site) interacting with CREB1, Ets2, Elf1, Elk1, and C/EBPα transcription factors; CpG DNA-mediated suppression of TLR9 transcription involves c-Jun and NF-κB p65.\",\n      \"method\": \"Reporter gene analysis, EMSA, transcription factor identification in human myeloma cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical methods (reporter + EMSA) in single cell type\",\n      \"pmids\": [\"15294971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DNA-containing immune complexes in lupus serum activate plasmacytoid DCs through cooperative interaction between TLR9 and FcγRIIa (CD32); CD32 delivers SLE immune complexes to intracellular lysosomes containing TLR9, inducing a signaling cascade leading to PDC activation.\",\n      \"method\": \"Subcellular co-localization microscopy, functional assays with CD32+ vs CD32- PDCs, cytokine measurement\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-localization, receptor-blocking experiments, and functional cytokine readout with defined receptor requirements\",\n      \"pmids\": [\"15668740\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DNA-PKcs, not TLR9, is the primary mediator of CpG-DNA-induced Akt phosphorylation and activation; in vitro reconstitution showed DNA-PK directly phosphorylates Akt, and DNA-PKcs associates with Akt upon CpG-DNA stimulation to trigger transient nuclear translocation of Akt in macrophages.\",\n      \"method\": \"DNA-PKcs and TLR9 KO macrophages, in vitro kinase assay with purified proteins, co-immunoprecipitation, nuclear fractionation\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified proteins plus genetic KO controls and Co-IP\",\n      \"pmids\": [\"15678105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Apical vs. basolateral TLR9 signaling in polarized intestinal epithelial cells produces distinct transcriptional responses: basolateral TLR9 activates NF-κB via IκBα degradation, whereas apical TLR9 stimulation causes ubiquitinated IκB accumulation without NF-κB activation and confers tolerance to subsequent TLR challenges, maintaining colonic homeostasis.\",\n      \"method\": \"Polarized epithelial cell culture, NF-κB reporter assays, cDNA microarray, TLR9-deficient mouse model of colitis\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined compartment-specific signaling with multiple readouts in both cell culture and in vivo KO model\",\n      \"pmids\": [\"17128265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The endosomal location of TLR9 activation—not oligonucleotide valency—determines the nature of the plasmacytoid DC response: TfR+ early endosomes drive IFN-α production while LAMP1+ lysosomes drive PDC maturation; altering CpG oligonucleotide localization by encapsulation redistributes the response.\",\n      \"method\": \"Endosomal fractionation, confocal microscopy, liposome encapsulation to redirect compartmental localization, cytokine assays in primary human PDCs\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple complementary experimental approaches establishing compartment-response relationship\",\n      \"pmids\": [\"16864658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Protein kinase D1 (PKD1) is activated downstream of TLR9 via a pathway requiring endosomal pH, MyD88, and IRAK1; upon CpG-B DNA stimulation PKD1 interacts with the TLR9/MyD88/IRAK1/TRAF6 complex and is required for NF-κB and MAPK activation and subsequent cytokine expression.\",\n      \"method\": \"PKD1 knockdown (siRNA), Co-immunoprecipitation, kinase activity assays, NF-κB reporter assays in macrophages\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP and KD in single lab with multiple pathway readouts\",\n      \"pmids\": [\"18641342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TLR9 is required for innate immune response to CpG DNA in chicken macrophages via a distinct receptor (chTLR21), demonstrating convergent evolution; in mammalian cells, TLR9 localizes to the same intracellular compartments as chTLR21, and endosomal maturation is required for functional signaling.\",\n      \"method\": \"Receptor cloning, HEK293 transfection, gene silencing in chicken macrophages, confocal microscopy, pharmacological inhibition\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional characterization with multiple methods; primarily characterizes chTLR21 but validates TLR9 endosomal localization and function\",\n      \"pmids\": [\"20498358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Cell-type-specific differences exist in TLR9 trafficking and proteolytic processing: in macrophages, TLR9 cleavage requires both cathepsins L and S, whereas in B cells only cathepsin L is required; processing rate is faster in B cells, which show predominantly endolysosomal TLR9 localization at rest; UNC93B1 expression level is tightly correlated with TLR9-GFP cleavage and is required for processing in all cell types.\",\n      \"method\": \"Transgenic TLR9-GFP mice, live-cell imaging, pharmacological cathepsin inhibition, UNC93B1 3d mutant mice\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic model with multiple cell types and pharmacological/genetic dissection of cathepsin requirements\",\n      \"pmids\": [\"23241879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TLR9 stimulation in cardiomyocytes and neurons activates a non-canonical pathway that reduces energy substrates, raises the AMP/ATP ratio, and activates AMPK to increase stress tolerance against hypoxia, without inducing canonical inflammatory responses; UNC93B1 expression acts as a pivotal switch regulating subcellular localization of TLR9 and determines which signaling pathway is activated in a cell-type-specific manner.\",\n      \"method\": \"Primary cardiomyocyte and neuronal culture, TLR9 stimulation, AMPK activity assays, metabolic measurements, UNC93B1 manipulation, hypoxia survival assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical readouts in primary cells with defined molecular switch (UNC93B1)\",\n      \"pmids\": [\"23479602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RNA:DNA hybrids are recognized by TLR9 as a novel molecular pattern; MyD88-dependent signaling is essential for cytokine responses induced by RNA:DNA hybrids containing viral sequences in dendritic cells.\",\n      \"method\": \"MyD88-deficient cells, TLR9-specific knockdown/KO, cytokine production assays, synthetic RNA:DNA hybrids\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO/KD with defined ligand in primary DCs\",\n      \"pmids\": [\"24514026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DNase II enzymatic activity is required for TLR9 activation by CpG-A (but not CpG-B) and by bacterial genomic DNA; DNase II cleaves CpG-A from 20-mer to 11–12-mer fragments, and these 3'-11-mer fragments activate DNase II-deficient DCs, demonstrating that TLR9 responds to DNA fragments generated by lysosomal DNase II rather than intact DNA.\",\n      \"method\": \"DNase II-deficient DCs, enzymatically inactive DNase II mutants, co-localization microscopy, stimulation with defined DNA fragments\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — enzymatic mutants plus KO cells plus defined fragment rescue, multiple orthogonal approaches\",\n      \"pmids\": [\"25600358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Dectin-1 controls TLR9 trafficking to phagosomes containing β-1,3 glucan via spleen tyrosine kinase (Syk) activation; phagosomal acidification and Dectin-1-mediated Syk signaling are both required for TLR9 accumulation at fungal phagosomes, and Dectin-1 regulates TLR9-dependent gene expression.\",\n      \"method\": \"Confocal microscopy, pharmacological inhibition of Syk and endosomal acidification, Dectin-1-deficient cells, gene expression assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined receptor requirements for trafficking with multiple inhibitor and genetic approaches\",\n      \"pmids\": [\"26829985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BAD-LAMP (LAMP5) controls TLR9 trafficking to LAMP1+ late endosomes in plasmacytoid DCs, promoting NF-κB activation and TNF production; a separate VAMP3+/LAMP2+/LAMP1- compartment supports IFN-α production, and BAD-LAMP silencing enhances TLR9 retention in this IFN-α-inducing compartment, while BAD-LAMP overexpression suppresses IFN-α.\",\n      \"method\": \"siRNA silencing, confocal microscopy, compartment characterization, cytokine measurement in primary human pDCs\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — compartment-specific trafficking with functional consequences defined by gain- and loss-of-function in primary cells\",\n      \"pmids\": [\"29030552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Glucocorticoid receptor (GR) suppresses TLR9-induced inflammation via a transcription-independent mechanism by physically interacting with IRAK1 and blocking β-TrCP-mediated K48-linked ubiquitination of IRAK1 at Lys134; this prevents membrane-to-cytoplasm trafficking of TRAF6 and TAK1 and downstream NF-κB/MAPK activation, an effect specific to TLR9 and not TLR4.\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis (K134 IRAK1), GR KO macrophages, ubiquitination assays, cytokine measurement\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis plus Co-IP plus KO macrophages establishing specific PTM requirement\",\n      \"pmids\": [\"29038250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Dengue virus (an RNA virus) activates TLR9 in human dendritic cells by inducing release of mitochondrial DNA (mtDNA) into the cytosol; this involves reactive oxygen species generation, inflammasome activation, disruption of TFAM-mtDNA association, and activation of mitochondrial permeability transition pores; both TLR9 and cGAS comparably contribute to DENV-induced immune activation.\",\n      \"method\": \"TLR9 and cGAS siRNA knockdown, TLR9 KO mouse bone marrow-derived DCs, mtDNA release quantification, ROS measurement, cytokine assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — parallel KD/KO with multiple mechanistic readouts, single study\",\n      \"pmids\": [\"29880709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CD82 (a tetraspanin) is a key regulator of TLR9 trafficking and signaling; TLR9 and CD82 associate in the ER and post-ER compartments of macrophages, and CD82 is essential for TLR9-dependent myddosome formation and NF-κB nuclear translocation in response to CpG stimulation.\",\n      \"method\": \"Co-immunoprecipitation, confocal microscopy, CD82-deficient macrophages, NF-κB nuclear translocation assays, myddosome complex analysis\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus functional KO with pathway readout in single study\",\n      \"pmids\": [\"31408613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Genetic dissection using TLR9 point mutants in lupus-prone mice revealed that TLR9 has distinct signaling modes: (1) a ligand- and MyD88-independent 'scaffold' protective function; (2) a ligand-dependent but MyD88-independent regulatory signaling function (B cell-intrinsic, restraining age-associated B cells and plasmablasts); and (3) a MyD88-dependent proinflammatory signaling function.\",\n      \"method\": \"TLR9 point mutant knockin mice (TLR9K51E lacking ligand binding; TLR9P915H lacking MyD88 binding), bone marrow chimeras, flow cytometry, disease phenotyping\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple precise knockin alleles plus chimera experiments dissecting distinct functional domains\",\n      \"pmids\": [\"36151396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TLR9 undergoes a cycle of S-palmitoylation and depalmitoylation that controls its endosomal signaling: DHHC3 palmitoylates TLR9 at C258 and C265 in the Golgi and regulates its trafficking to endosomes; PPT1 removes S-palmitoylation from TLR9 in lysosomes and facilitates TLR9 release from UNC93B1, promoting IFN-α secretion by pDCs and TNF by macrophages.\",\n      \"method\": \"Mass spectrometry (palmitoylation site identification), site-directed mutagenesis (C258/C265), PPT1 KO/inhibition, DHHC3 manipulation, biochemical palmitoylation assays, cytokine measurements in vitro and in vivo\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — MS-identified PTM sites confirmed by mutagenesis, genetic KO and chemical inhibition with multiple orthogonal readouts\",\n      \"pmids\": [\"38169466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TLR9 signaling in hippocampal CA1 neurons is required for memory formation; learning induces dsDNA breaks and nuclear envelope ruptures in discrete neuronal clusters, triggering TLR9 activation; neuron-specific Tlr9 knockdown impairs contextual fear memory and TLR9 has an essential role in centrosome function including DNA damage repair, ciliogenesis, and perineuronal net formation.\",\n      \"method\": \"Neuron-specific Tlr9 knockdown, contextual fear conditioning, gene expression profiling of CA1 neuron clusters, centrosome functional assays, imaging of dsDNA breaks\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — neuron-specific KD with behavioral and molecular phenotypes, single study\",\n      \"pmids\": [\"38538785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"EBV suppresses TLR9 expression by downregulating N6-methyladenosine (m6A) modification of TLR9 mRNA; EBNA1 promotes K48-linked ubiquitin-proteasome degradation of METTL3 (m6A writer), reducing TLR9 mRNA stability; YTHDF1 acts as an m6A reader that enhances TLR9 translation, and loss of METTL3/YTHDF1 reduces TLR9 protein expression and impairs TLR9-dependent B cell responses.\",\n      \"method\": \"METTL3/YTHDF1 knockdown, m6A site mapping, ubiquitination assays, protein stability assays, B cell functional assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple molecular components identified with loss-of-function, single study\",\n      \"pmids\": [\"38537697\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TLR9 is an endosomal pattern recognition receptor that resides in the ER at steady state and, upon CpG DNA uptake, translocates to lysosomes where it directly binds unmethylated CpG DNA at acidic pH (facilitated by DNase II-generated fragments and S-palmitoylation cycling by DHHC3/PPT1 that controls its association with the trafficking chaperone UNC93B1); ligand engagement initiates MyD88-dependent signaling through IRAK1 (regulated by ubiquitination and PKD1), with signaling outcome determined by subcellular compartment—early endosomes driving IFN-α production and late lysosomes driving NF-κB/TNF responses—while accessory proteins including CD32, BAD-LAMP, CD82, and Dectin-1 regulate TLR9 trafficking to specific compartments; beyond immune cells, TLR9 activates AMPK-dependent stress protection in cardiomyocytes/neurons and, via a MyD88-independent scaffold function in B cells, suppresses lupus pathogenesis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TLR9 is an endosomal pattern recognition receptor that detects unmethylated CpG DNA, RNA:DNA hybrids, and mitochondrial DNA to initiate innate immune signaling and, in neurons, participates in DNA damage-associated centrosome function and memory formation. At steady state TLR9 resides in the ER; upon stimulation it traffics to endolysosomes in a process regulated by UNC93B1, S-palmitoylation cycling (DHHC3/PPT1), the ESCRT component HRS, and the tetraspanin CD82, where cathepsin-mediated proteolytic cleavage generates the active receptor that signals through a MyD88–IRAK1–TRAF6–NF-κB/MAPK cascade requiring PKD1 and BTK [PMID:15588423, PMID:23241879, PMID:38169466, PMID:18641342, PMID:24612681]. Subcellular compartmentalization determines signaling outcome: BAD-LAMP directs TLR9 to LAMP1⁺ late endosomes for NF-κB–driven cytokine production, whereas retention in a VAMP3⁺/LAMP2⁺ compartment promotes type I interferon expression [PMID:29030552]. Beyond canonical ligand-dependent signaling, TLR9 possesses MyD88-independent scaffold functions in B cells that restrain autoreactive B cell differentiation into pathogenic age-associated B cells and plasmablasts, conferring protection from lupus nephritis [PMID:36151396, PMID:32191633].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Defining how TLR9 gene expression is transcriptionally controlled revealed that multiple cis-elements and transcription factors (CREB1, Ets2, Elf1, C/EBPα) drive TLR9 transcription, while CpG-induced c-Jun and NF-κB p65 feed back to suppress it.\",\n      \"evidence\": \"Reporter gene and EMSA analysis in RPMI 8226 myeloma cells\",\n      \"pmids\": [\"15294971\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Regulation in primary immune cells not validated\", \"Post-transcriptional and epitranscriptomic regulation not addressed at this stage\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Establishing the subcellular itinerary of TLR9 — ER residence at rest and ligand-triggered translocation to CpG-containing endolysosomal compartments — defined compartmentalized activation as a core principle of TLR9 biology, and showed that FcγRIIa delivers DNA-immune complexes to TLR9-containing lysosomes, linking this receptor to lupus pathogenesis.\",\n      \"evidence\": \"GFP-tagged TLR9 live-cell imaging, subcellular fractionation in pDCs, CD32 sorting and blocking in lupus-serum-stimulated pDCs\",\n      \"pmids\": [\"15588423\", \"15668740\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular machinery controlling ER-to-endosome trafficking not yet identified\", \"Whether CpG-DNA-independent Akt activation by DNA-PKcs feeds back to TLR9 signaling unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of PKD1 as a signaling kinase recruited to the TLR9/MyD88/IRAK1/TRAF6 complex established a kinase cascade required for NF-κB and MAPK activation downstream of endosomal TLR9, while parallel work showed TLR9 engagement on hepatic stellate cells drives fibrosis via MCP-1.\",\n      \"evidence\": \"Co-IP, siRNA knockdown, and kinase assays in macrophages; TLR9-knockout mouse bile duct ligation model for fibrosis\",\n      \"pmids\": [\"18641342\", \"18760996\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PKD1 phosphorylation site on TLR9 complex components not mapped\", \"How stellate cell TLR9 ligand access differs from immune cells undetermined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrating that cell-type-specific cathepsin-mediated proteolytic cleavage of TLR9 is required for activation — with cathepsins L and S in macrophages vs. cathepsin L alone in B cells — and that UNC93B1 levels control cleavage efficiency, established proteolytic processing as a gating step; concurrently, HRS was identified as required for ubiquitin-dependent TLR9 endolysosomal targeting.\",\n      \"evidence\": \"Transgenic TLR9-GFP mice with pharmacological cathepsin inhibition and UNC93B1 3d mutant; genome-wide RNAi screen for TLR9 trafficking regulators\",\n      \"pmids\": [\"23241879\", \"22423970\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact cleavage sites on TLR9 for each cathepsin not resolved\", \"How ubiquitin ligases targeting TLR9 for HRS recognition are regulated is unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Expanding the ligand repertoire of TLR9 beyond CpG DNA, RNA:DNA hybrids were shown to activate TLR9 in a MyD88-dependent manner, while BTK was identified as essential for TLR9-dependent DC activation using XLA patient cells.\",\n      \"evidence\": \"TLR9-KO and MyD88-deficient cells stimulated with RNA:DNA hybrids; DCs from BTK-deficient XLA patients and ibrutinib-treated controls\",\n      \"pmids\": [\"24514026\", \"24612681\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding mode of RNA:DNA hybrids to TLR9 ectodomain not structurally resolved\", \"Where BTK acts in the TLR9 signaling cascade (direct substrate vs. scaffold) not determined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"DNase II was shown to be required upstream of TLR9 activation: it processes CpG-DNA into specific 11–12-mer fragments in endolysosomes that serve as the true TLR9-activating ligand, while TLR9-deficient B cells revealed an intrinsic regulatory role for TLR9 in restraining autoreactive plasma cell differentiation.\",\n      \"evidence\": \"DNase II-deficient DCs with synthetic fragment rescue; comparative WT/TLR9-KO/TLR7-KO B cell proliferation and differentiation assays\",\n      \"pmids\": [\"25600358\", \"25681333\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DNase II processing is required for all TLR9 ligand classes (e.g. RNA:DNA hybrids, mtDNA) not tested\", \"Molecular mechanism by which TLR9 restrains plasma cell differentiation unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Mitochondrial DNA released from damaged hepatocytes was established as an endogenous TLR9 ligand driving NASH through macrophage TLR9, while Dectin-1/Syk signaling was shown to actively direct TLR9 trafficking to phagosomes, revealing receptor crosstalk that controls TLR9 compartmentalization.\",\n      \"evidence\": \"Conditional TLR9 KO in macrophage lineage on high-fat diet; fluorescence microscopy of TLR9 redistribution to β-glucan-containing phagosomes with Syk inhibition\",\n      \"pmids\": [\"26808498\", \"26829985\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether oxidized vs. unoxidized mtDNA differentially activates TLR9 not resolved\", \"Molecular link between Syk and TLR9 transport machinery not identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"BAD-LAMP (LAMP5) was identified as a trafficking switch that directs TLR9 to distinct endosomal compartments in pDCs — LAMP1⁺ endosomes for NF-κB/TNF versus VAMP3⁺/LAMP2⁺ compartments for type I IFN — mechanistically explaining how one receptor produces divergent outputs, while GR–IRAK1 interaction was shown to selectively suppress TLR9 (but not TLR4) signaling via blocking K48-ubiquitination of IRAK1.\",\n      \"evidence\": \"BAD-LAMP siRNA with compartment-specific imaging and cytokine assays in primary pDCs; GR-KO macrophages with IRAK1 K134 mutagenesis and ubiquitination assays\",\n      \"pmids\": [\"29030552\", \"29038250\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How BAD-LAMP expression itself is regulated in pDCs unknown\", \"Whether GR–IRAK1 regulation operates in non-macrophage TLR9-expressing cells not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Two studies established that mitochondrial stress — viral (dengue) or genetic (Opa1 deficiency) — releases mtDNA that cell-autonomously activates TLR9–NF-κB signaling in diverse non-immune cell types (DCs during infection, muscle cells), broadening TLR9's role as a sensor of mitochondrial integrity.\",\n      \"evidence\": \"TLR9 knockdown/KO in dengue-infected DCs with mtDNA detection; muscle-specific Opa1-KO with TLR9 blockade preventing NF-κB activation\",\n      \"pmids\": [\"29880709\", \"29632021\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether cytosolic vs. endosomal mtDNA sensing by TLR9 requires distinct trafficking routes not resolved\", \"Contribution of cGAS-STING vs. TLR9 in mtDNA sensing not fully delineated in these tissues\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"CD82 was identified as an ER-resident TLR9 partner essential for myddosome formation and NF-κB signaling, while PINK1-dependent mtDNA oxidation/release was linked to TLR9-mediated profibrotic TGF-β production in alveolar epithelial cells.\",\n      \"evidence\": \"Reciprocal Co-IP and CD82-KO macrophages; PINK1 knockdown/overexpression with TLR9 activation and TGF-β assays in AECII\",\n      \"pmids\": [\"31408613\", \"31170232\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD82 directly contacts TLR9 or acts via membrane organization not distinguished\", \"Mechanism by which TLR9 triggers TGF-β rather than inflammatory cytokines in epithelial cells unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Reciprocal gain- and loss-of-function experiments in lupus-prone mice definitively established that B cell-intrinsic TLR9 protects from nephritis, paradoxically opposing the proinflammatory role of TLR9 in myeloid cells.\",\n      \"evidence\": \"Conditional B cell-specific Tlr9 deletion and overexpression alleles crossed to lupus-prone mice\",\n      \"pmids\": [\"32191633\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling pathway mediating TLR9's protective B cell-intrinsic function not identified at this point\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Structure-function dissection using TLR9 point mutants in lupus mice revealed three separable functional modes: ligand/MyD88-independent scaffold function, ligand-dependent but MyD88-independent regulatory signaling, and classical MyD88-dependent inflammatory signaling, explaining how TLR9 simultaneously protects and harms in autoimmunity.\",\n      \"evidence\": \"TLR9K51E and TLR9P915H knock-in mutants in MRL/lpr mice with mixed bone marrow chimeras\",\n      \"pmids\": [\"36151396\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular partners mediating the scaffold (MyD88-independent) function are unknown\", \"Whether these functional modes operate in non-B cell lineages not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Three discoveries expanded TLR9 biology in unexpected directions: S-palmitoylation cycling (DHHC3 palmitoylation in Golgi, PPT1 depalmitoylation in lysosomes) was shown to regulate TLR9 trafficking and UNC93B1 release; EBV was found to suppress TLR9 expression via EBNA1-mediated METTL3 degradation reducing m6A modification of TLR9 mRNA; and neuronal TLR9 was shown to respond to learning-induced DNA breaks to organize centrosome-dependent repair and memory circuit formation.\",\n      \"evidence\": \"Mass spectrometry palmitoylation mapping with DHHC3/PPT1 KO and chemical inhibition; m6A-seq with METTL3/YTHDF1 identification in EBV models; neuron-specific Tlr9 knockdown with fear conditioning and centrosome imaging\",\n      \"pmids\": [\"38169466\", \"38537697\", \"38538785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether palmitoylation regulates other endosomal TLRs via the same mechanism untested\", \"Structural basis for TLR9 sensing of dsDNA breaks at centrosomes unknown\", \"Whether YTHDF1-dependent TLR9 translation regulation operates beyond EBV infection contexts not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the molecular identity of partners mediating TLR9's MyD88-independent scaffold function in B cells, the structural basis for TLR9 recognition of diverse nucleic acid ligands (CpG DNA fragments, RNA:DNA hybrids, oxidized mtDNA), and how non-immune cell types (neurons, cardiomyocytes) achieve distinct TLR9 signaling outcomes without canonical inflammatory cascades.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of TLR9 bound to processed DNA fragments or RNA:DNA hybrids\", \"Scaffold interactors in B cells unidentified\", \"Neuronal TLR9 signaling pathway downstream of centrosome association not mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 3, 6, 15, 16, 17, 25]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 5, 6]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 10]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [0, 4, 7, 9, 11]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [1, 5, 7, 8]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 1, 3, 5, 6, 7, 10, 19, 20]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 18, 24]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 15, 20, 21, 22]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0, 7, 8, 9, 11]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"complexes\": [\n      \"Myddosome (TLR9/MyD88/IRAK1/TRAF6)\"\n    ],\n    \"partners\": [\n      \"MYD88\",\n      \"IRAK1\",\n      \"TRAF6\",\n      \"UNC93B1\",\n      \"CD82\",\n      \"PRKD1\",\n      \"BTK\",\n      \"LAMP5\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"TLR9 is an endosomal pattern recognition receptor that detects unmethylated CpG DNA and RNA:DNA hybrids to initiate innate immune signaling, with additional non-canonical roles in stress tolerance and neuronal function. At steady state TLR9 resides in the ER and, upon ligand uptake, translocates to endolysosomes where it directly binds CpG DNA at acidic pH; this trafficking requires UNC93B1, proteolytic processing by cathepsins, and a palmitoylation–depalmitoylation cycle mediated by DHHC3 and PPT1 that controls UNC93B1 release and downstream signaling output [PMID:14716310, PMID:23241879, PMID:38169466]. The signaling outcome is compartment-determined: TLR9 activation in early endosomes drives IFN-α production whereas activation in late lysosomes drives NF-κB–dependent TNF responses, with accessory proteins BAD-LAMP, CD82, CD32, and Dectin-1 directing TLR9 to specific compartments [PMID:16864658, PMID:29030552, PMID:15668740, PMID:26829985]. Genetic dissection in lupus-prone mice revealed that TLR9 possesses a MyD88-independent scaffold function that is B cell-intrinsic and protective against autoimmunity, separable from its ligand-dependent proinflammatory signaling [PMID:36151396].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing TLR9 as the non-redundant receptor for bacterial CpG DNA resolved the long-standing question of how the innate immune system discriminates microbial from self-DNA.\",\n      \"evidence\": \"TLR9 knockout mice showing complete loss of CpG DNA responses across multiple readouts (proliferation, cytokines, DC maturation, Th1 polarization)\",\n      \"pmids\": [\"11130078\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ligand binding mechanism not yet defined\", \"Subcellular site of receptor activation unknown\", \"Signaling intermediates downstream of TLR9 not mapped\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The discovery that TLR9 resides in the ER and must translocate to CpG-containing lysosomes to signal overturned the assumption that TLR activation occurs at the plasma membrane, establishing a new paradigm of intracellular innate receptor activation.\",\n      \"evidence\": \"Fluorescence microscopy and subcellular fractionation in primary DCs and macrophages showing ER residence and ligand-induced redistribution to LAMP1+ compartments with MyD88 co-recruitment\",\n      \"pmids\": [\"14716310\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular chaperone(s) required for ER-to-endosome trafficking not identified\", \"Mechanism of pH-dependent ligand recognition not resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating direct, pH-dependent, sequence-specific CpG DNA binding by TLR9 and identifying a CpG-binding domain resolved how ligand specificity is achieved in the acidic endolysosomal environment.\",\n      \"evidence\": \"Direct binding assays at acidic pH combined with site-directed mutagenesis abolishing both binding and NF-κB activation\",\n      \"pmids\": [\"15307186\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of TLR9–CpG complex not available\", \"Structural basis for methylation discrimination unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identifying that FcγRIIa (CD32) delivers DNA-containing immune complexes to TLR9-positive lysosomes in plasmacytoid DCs provided a mechanistic link between autoantibody-mediated uptake and TLR9 activation in systemic lupus erythematosus.\",\n      \"evidence\": \"Co-localization of CD32-internalized SLE immune complexes with TLR9 in lysosomes; receptor-blocking experiments abolishing PDC activation\",\n      \"pmids\": [\"15668740\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of CD32-dependent vs -independent uptake in different DC subsets unclear\", \"Whether other Fc receptors cooperate not tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating that the endosomal compartment of TLR9 activation—early endosome vs. late lysosome—determines whether IFN-α or NF-κB/maturation responses are elicited established compartmentalized signaling as a core principle of TLR9 biology.\",\n      \"evidence\": \"Endosomal fractionation and liposome-mediated redirection of CpG localization in primary human pDCs with cytokine readouts\",\n      \"pmids\": [\"16864658\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific adaptor molecules distinguishing compartment-specific signaling not fully identified\", \"How retention time in each compartment is regulated unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showing that apical vs. basolateral TLR9 stimulation in polarized epithelial cells produces opposing NF-κB outcomes extended TLR9 compartment-dependent signaling to non-immune cells and implicated it in intestinal homeostasis.\",\n      \"evidence\": \"Polarized epithelial cell culture with NF-κB reporters and microarray, plus TLR9-deficient colitis model\",\n      \"pmids\": [\"17128265\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of apical I-κBα ubiquitination without degradation not defined\", \"In vivo epithelial-specific TLR9 contribution not separated from immune cell contribution\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying cell-type-specific cathepsin requirements for TLR9 proteolytic processing and demonstrating UNC93B1 as a universal regulator of this processing clarified how TLR9 activation is differentially tuned across immune lineages.\",\n      \"evidence\": \"TLR9-GFP transgenic mice analyzed in macrophages and B cells with cathepsin inhibitors and UNC93B1 3d mutant mice\",\n      \"pmids\": [\"23241879\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise cleavage sites in TLR9 not mapped\", \"Functional consequence of differential processing kinetics on signaling output not quantified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Discovery of a non-canonical TLR9–AMPK stress-protection pathway in cardiomyocytes and neurons, gated by UNC93B1 expression level, revealed that TLR9 functions beyond immunity as a metabolic sensor in non-immune cells.\",\n      \"evidence\": \"Primary cardiomyocyte and neuronal cultures showing CpG-induced AMP/ATP ratio increase, AMPK activation, and hypoxia protection without inflammatory cytokine induction; UNC93B1 manipulation switching pathway usage\",\n      \"pmids\": [\"23479602\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous ligand triggering this pathway in vivo not identified\", \"Whether AMPK activation is direct or through intermediate kinases unknown\", \"Not independently replicated in a second laboratory\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Establishing that DNase II generates the short CpG DNA fragments actually recognized by TLR9 in lysosomes redefined the ligand from intact CpG DNA to processed 11–12-mer fragments for at least some agonist classes.\",\n      \"evidence\": \"DNase II-deficient and enzymatically dead DCs showing loss of CpG-A responses; rescue by synthetic 3'-11-mer fragments\",\n      \"pmids\": [\"25600358\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether all TLR9 ligand classes require DNase II processing not resolved\", \"Structural basis for fragment-length preference unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of BAD-LAMP as a trafficking regulator that directs TLR9 toward LAMP1+ late endosomes (promoting NF-κB/TNF) and away from VAMP3+/LAMP2+ IFN-α-inducing compartments provided a molecular handle on compartment-dependent signaling in pDCs.\",\n      \"evidence\": \"BAD-LAMP silencing and overexpression in primary human pDCs with compartment characterization and cytokine quantification\",\n      \"pmids\": [\"29030552\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"BAD-LAMP interaction surface on TLR9 not mapped\", \"Whether BAD-LAMP regulates other endosomal TLRs not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstration that glucocorticoid receptor suppresses TLR9-specific signaling by physically blocking IRAK1 K48-ubiquitination at K134 revealed a transcription-independent anti-inflammatory checkpoint unique to the TLR9 pathway.\",\n      \"evidence\": \"GR KO macrophages, IRAK1 K134 mutagenesis, ubiquitination assays, and Co-IP showing GR–IRAK1 interaction\",\n      \"pmids\": [\"29038250\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GR-IRAK1 interaction is direct or requires bridging factors not confirmed with purified proteins\", \"In vivo relevance of K134-specific ubiquitination not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Genetic separation of TLR9 into three functional modes—ligand/MyD88-independent scaffold, ligand-dependent/MyD88-independent regulatory, and MyD88-dependent proinflammatory—overturned the linear receptor-signaling model and showed that TLR9's protective role in lupus operates via a B cell-intrinsic scaffold function.\",\n      \"evidence\": \"TLR9 K51E (no ligand binding) and P915H (no MyD88 recruitment) knockin alleles in lupus-prone mice with bone marrow chimeras\",\n      \"pmids\": [\"36151396\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular partners for the scaffold function not identified\", \"Whether scaffold function involves other TIR-domain interactions unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of a DHHC3/PPT1-mediated palmitoylation–depalmitoylation cycle on TLR9 C258/C265 that controls UNC93B1 release and signaling output provided the first lipid-modification mechanism governing TLR9 endosomal trafficking and activation.\",\n      \"evidence\": \"Mass spectrometry palmitoylation site mapping, C258/C265 mutagenesis, PPT1 KO/inhibition, DHHC3 manipulation with cytokine readouts in vivo and in vitro\",\n      \"pmids\": [\"38169466\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other palmitoyl-acyltransferases contribute redundantly not excluded\", \"Structural consequences of palmitoylation on TLR9–UNC93B1 interface not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery that learning-induced DNA damage activates neuronal TLR9 for memory formation, linking TLR9 to centrosome function and ciliogenesis in neurons, opened an entirely non-immune role for TLR9 in cognitive processes.\",\n      \"evidence\": \"Neuron-specific Tlr9 knockdown impairing contextual fear memory; gene profiling showing centrosome, DNA repair, and perineuronal net pathways\",\n      \"pmids\": [\"38538785\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether endogenous nuclear DNA fragments are the physiological TLR9 ligand in neurons is unconfirmed\", \"Mechanism linking TLR9 to centrosome function not characterized\", \"Single study, not independently replicated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of molecular partners mediating TLR9's MyD88-independent scaffold function, the structural basis of compartment-specific signaling complex assembly, and whether neuronal and cardiomyocyte TLR9 functions use the same or distinct ligand-processing and trafficking machinery as immune cells.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Scaffold function partners unidentified\", \"No high-resolution structure of full-length TLR9 in complex with signaling adaptors\", \"Endogenous ligands in non-immune contexts not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 2, 12]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [2, 13]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 10, 18]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [1, 7, 13, 15]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [7, 9, 15, 20]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 2, 4, 7, 12, 13, 15, 16, 19]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 7, 8, 11, 16, 19]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 17, 22]}\n    ],\n    \"complexes\": [\n      \"TLR9–UNC93B1 trafficking complex\",\n      \"TLR9–MyD88–IRAK1–TRAF6 myddosome\"\n    ],\n    \"partners\": [\n      \"MYD88\",\n      \"UNC93B1\",\n      \"IRAK1\",\n      \"TRAF6\",\n      \"CD82\",\n      \"ZDHHC3\",\n      \"PPT1\",\n      \"LAMP5\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}